secwatch.observer — SEC 8-K summary
======================================

Issuer:     Caring Brands, Inc. (CABR)
CIK:        0002020737
Form:       8-K
Filed at:   2026-01-05T23:59:59+00:00
Accession:  0001493152-26-000286
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Caring Brands enters exclusive global license for Emesyl nausea relief product
------------------------------------------------------------------------------

- Licensed Emesyl OTC nausea product from Itonis; exclusive worldwide rights to manufacture, market, distribute.
- 8% royalty on net sales; potential to earn 7% of Itonis equity per $200k in sales.
- License may terminate if sales ≤$25k for four consecutive quarters after launch.
- Global nausea treatment market projected >$6.23B in 2025, per QY Research.
- CEO notes expansion of health/wellness portfolio; further updates expected on timelines.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2020737/000149315226000286/0001493152-26-000286-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2020737/000149315226000286/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-000286

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer